VRCA · CIK 0001660334 · operating
Verrica Pharmaceuticals Inc. (VRCA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $89 million, Verrica Pharmaceuticals Inc. is a micro-cap company. The stock currently trades at $5.39, down 1.46% today, with a 52-week range of $3.28–$9.82.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.48 | $-1.48 | +0.0% | |
| 2023 | $-1.48 | $-1.48 | -105.6% | |
| 2022 | $-0.72 | $-0.72 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-11 | 0000950170-25-037172 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0000950170-24-022659 | SEC ↗ |
| 2022-12-31 | 2023-03-06 | 0000950170-23-006118 | SEC ↗ |
| 2021-12-31 | 2022-03-02 | 0000950170-22-002685 | SEC ↗ |
| 2020-12-31 | 2021-03-17 | 0001564590-21-013876 | SEC ↗ |
| 2019-12-31 | 2020-03-13 | 0001564590-20-010832 | SEC ↗ |
| 2018-12-31 | 2019-03-07 | 0001564590-19-006800 | SEC ↗ |